Recursion Pharmaceuticals (RXRX) CEO Sells 100,000 Shares
Werte in diesem Artikel
Christopher Gibson, Chief Executive Officer of Recursion Pharmaceuticals (NASDAQ:RXRX), reported the sale of 100,000 shares on October 10, 2025, as disclosed in a SEC Form 4 filing. It appears that Gibson converted 120,000 shares of class B common stock to class A common stock. He then sold 100,00 shares for $604,000 and gifted 20,000 shares to an undisclosed party.Transaction value is based on the SEC Form 4 weighted average purchase price ($6.04) as reported for the transaction on October 10, 2025.How does the scale of this transaction compare to Christopher Gibson's historical trading activity?This transaction aligns with the recent median sell size of 100,000 shares for trades from May 2, 2024, to October 10, 2025. Since May 2024, Gibson has executed 17 sell trades with a median size of 100,000 shares [Source: insider trading statistics, period: May 2, 2024, to October 10, 2025], indicating this event is typical in magnitude for his recent activity.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Recursion Pharmaceuticals, A
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Recursion Pharmaceuticals, A
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: MotleyFool
Nachrichten zu Recursion Pharmaceuticals, Inc Registered Shs -A-
Analysen zu Recursion Pharmaceuticals, Inc Registered Shs -A-
Keine Analysen gefunden.